Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK)
HKD 1.39
(-0.71%)
HKD 1.39
(-0.71%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.31 Billion CNY | -2.28% |
| 2022 | 2.37 Billion CNY | 14.5% |
| 2021 | 2.07 Billion CNY | 14.84% |
| 2020 | 1.8 Billion CNY | 7.96% |
| 2019 | 1.67 Billion CNY | 7.5% |
| 2018 | 1.55 Billion CNY | 25.59% |
| 2017 | 1.23 Billion CNY | 15.14% |
| 2016 | 1.07 Billion CNY | 18.42% |
| 2015 | 907.99 Million CNY | 15.86% |
| 2014 | 783.66 Million CNY | 20.54% |
| 2013 | 650.12 Million CNY | 21.28% |
| 2012 | 536.05 Million CNY | 17.09% |
| 2011 | 457.81 Million CNY | 20.58% |
| 2010 | 379.67 Million CNY | 13.07% |
| 2009 | 335.79 Million CNY | 5.58% |
| 2008 | 318.04 Million CNY | 13.0% |
| 2007 | 281.46 Million CNY | 7.57% |
| 2006 | 261.66 Million CNY | -1.31% |
| 2005 | 265.13 Million CNY | 3.79% |
| 2004 | 255.46 Million CNY | 4.67% |
| 2003 | 244.07 Million CNY | 8.35% |
| 2002 | 225.25 Million CNY | -2.25% |
| 2001 | 230.44 Million CNY | 82.29% |
| 2000 | 126.41 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.36 Billion CNY | 1.98% |
| 2024 Q2 | 2.36 Billion CNY | 0.0% |
| 2023 Q2 | 2.32 Billion CNY | 0.0% |
| 2023 Q3 | - CNY | -100.0% |
| 2023 Q1 | - CNY | -100.0% |
| 2023 FY | 2.31 Billion CNY | -2.28% |
| 2023 Q4 | 2.31 Billion CNY | 0.0% |
| 2022 FY | 2.37 Billion CNY | 14.5% |
| 2022 Q4 | 2.37 Billion CNY | 0.0% |
| 2022 Q3 | - CNY | -100.0% |
| 2022 Q1 | - CNY | -100.0% |
| 2022 Q2 | 2.16 Billion CNY | 0.0% |
| 2021 FY | 2.07 Billion CNY | 14.84% |
| 2021 Q2 | 1.89 Billion CNY | 0.0% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 Q4 | 2.07 Billion CNY | 0.0% |
| 2020 FY | 1.8 Billion CNY | 7.96% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q2 | 1.69 Billion CNY | 0.0% |
| 2020 Q4 | 1.8 Billion CNY | 0.0% |
| 2019 Q4 | 1.67 Billion CNY | 0.0% |
| 2019 Q2 | 1.57 Billion CNY | 0.0% |
| 2019 FY | 1.67 Billion CNY | 7.5% |
| 2018 Q1 | - CNY | -100.0% |
| 2018 Q4 | 1.55 Billion CNY | 0.0% |
| 2018 Q2 | 1.31 Billion CNY | 0.0% |
| 2018 FY | 1.55 Billion CNY | 25.59% |
| 2017 Q2 | 1.21 Billion CNY | 0.0% |
| 2017 Q4 | 1.23 Billion CNY | 0.0% |
| 2017 FY | 1.23 Billion CNY | 15.14% |
| 2017 Q1 | - CNY | -100.0% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 FY | 1.07 Billion CNY | 18.42% |
| 2016 Q4 | 1.07 Billion CNY | 0.0% |
| 2016 Q2 | 1 Billion CNY | 0.0% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 Q2 | 846.54 Million CNY | 0.0% |
| 2015 Q4 | 907.99 Million CNY | 0.0% |
| 2015 FY | 907.99 Million CNY | 15.86% |
| 2014 Q4 | 783.66 Million CNY | 0.0% |
| 2014 FY | 783.66 Million CNY | 20.54% |
| 2014 Q2 | 724.99 Million CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2013 Q1 | - CNY | -100.0% |
| 2013 Q4 | 650.12 Million CNY | 0.0% |
| 2013 Q2 | 644.06 Million CNY | 0.0% |
| 2013 FY | 650.12 Million CNY | 21.28% |
| 2012 Q4 | 536.05 Million CNY | 0.0% |
| 2012 Q2 | 504.84 Million CNY | 0.0% |
| 2012 FY | 536.05 Million CNY | 17.09% |
| 2011 Q4 | 457.81 Million CNY | 0.0% |
| 2011 FY | 457.81 Million CNY | 20.58% |
| 2011 Q2 | 435.5 Million CNY | 0.0% |
| 2010 Q4 | 379.67 Million CNY | 0.0% |
| 2010 Q2 | 380.32 Million CNY | 0.0% |
| 2010 FY | 379.67 Million CNY | 13.07% |
| 2009 FY | 335.79 Million CNY | 5.58% |
| 2008 FY | 318.04 Million CNY | 13.0% |
| 2007 FY | 281.46 Million CNY | 7.57% |
| 2006 FY | 261.66 Million CNY | -1.31% |
| 2005 FY | 265.13 Million CNY | 3.79% |
| 2004 FY | 255.46 Million CNY | 4.67% |
| 2003 FY | 244.07 Million CNY | 8.35% |
| 2002 FY | 225.25 Million CNY | -2.25% |
| 2001 FY | 230.44 Million CNY | 82.29% |
| 2000 FY | 126.41 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -155.528% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | 89.701% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -80.146% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | -10.678% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -384.991% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | 19.782% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | 17.992% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | -34.243% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -174.754% |
| SSY Group Limited | 11.96 Billion HKD | 80.622% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | -66.978% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | 33.498% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 99.147% |